Found: 266
Select item for more details and to access through your institution.
Effect of dapagliflozin on kidney and cardiovascular outcomes by baseline KDIGO risk categories: a post hoc analysis of the DAPA-CKD trial.
- Published in:
- Diabetologia, 2022, v. 65, n. 7, p. 1085, doi. 10.1007/s00125-022-05694-6
- By:
- Publication type:
- Article
SGLT2 inhibitors and mechanisms of cardiovascular benefit: a state-of-the-art review.
- Published in:
- Diabetologia, 2018, v. 61, n. 10, p. 2108, doi. 10.1007/s00125-018-4670-7
- By:
- Publication type:
- Article
Three-question set from Michigan Neuropathy Screening Instrument adds independent prognostic information on cardiovascular outcomes: analysis of ALTITUDE trial.
- Published in:
- Diabetologia, 2018, v. 61, n. 3, p. 581, doi. 10.1007/s00125-017-4485-y
- By:
- Publication type:
- Article
Impaired endothelium‐dependent vasodilatation in uraemia.
- Published in:
- Nephrology Dialysis Transplantation, 2000, v. 15, n. 8, p. 1194, doi. 10.1093/ndt/15.8.1194
- By:
- Publication type:
- Article
Pro‐gastrin‐releasing peptide and outcome in patients with heart failure and anaemia: results from the RED‐HF study.
- Published in:
- ESC Heart Failure, 2018, v. 5, n. 6, p. 1052, doi. 10.1002/ehf2.12312
- By:
- Publication type:
- Article
Efficacy and Safety of Dapagliflozin in Patients With Chronic Kidney Disease Across the Spectrum of Frailty.
- Published in:
- Journals of Gerontology Series A: Biological Sciences & Medical Sciences, 2024, v. 79, n. 2, p. 1, doi. 10.1093/gerona/glad181
- By:
- Publication type:
- Article
Effect of albiglutide on cardiovascular outcomes in older adults: A post hoc analysis of a randomized controlled trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 5, p. 1714, doi. 10.1111/dom.15479
- By:
- Publication type:
- Article
Meta‐analysis of risk of major adverse cardiovascular events in adults with type 2 diabetes treated with bexagliflozin.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 3, p. 971, doi. 10.1111/dom.15394
- By:
- Publication type:
- Article
Estimated lifetime benefit of novel pharmacological therapies in patients with type 2 diabetes and chronic kidney disease: A joint analysis of randomized controlled clinical trials.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 11, p. 3327, doi. 10.1111/dom.15232
- By:
- Publication type:
- Article
Effect of lixisenatide on natriuretic peptides in people with type 2 diabetes and recent acute coronary syndrome: The ELIXA trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 4, p. 1125, doi. 10.1111/dom.14954
- By:
- Publication type:
- Article
Re‐examining the widespread policy of stopping sodium‐glucose cotransporter‐2 inhibitors during acute illness: A perspective based on the updated evidence.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 11, p. 2071, doi. 10.1111/dom.14805
- By:
- Publication type:
- Article
Quételet (body mass) index and effects of dapagliflozin in chronic kidney disease.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 5, p. 827, doi. 10.1111/dom.14641
- By:
- Publication type:
- Article
Inter‐individual variability in atrasentan exposure partly explains variability in kidney protection and fluid retention responses: A post hoc analysis of the SONAR trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 2, p. 561, doi. 10.1111/dom.14252
- By:
- Publication type:
- Article
N‐terminal pro‐brain natriuretic peptide (NT‐proBNP) predicts the cardio‐renal response to aliskiren in patients with type 2 diabetes at high renal and cardiovascular risk.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 12, p. 2899, doi. 10.1111/dom.13465
- By:
- Publication type:
- Article
Why do SGLT2 inhibitors reduce heart failure hospitalization? A differential volume regulation hypothesis.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 3, p. 479, doi. 10.1111/dom.13126
- By:
- Publication type:
- Article
Effect of valsartan on kidney outcomes in people with impaired glucose tolerance.
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 6, p. 791, doi. 10.1111/dom.12877
- By:
- Publication type:
- Article
Effects of tezosentan on symptoms and clinical outcomes in patients with acute heart failure: the VERITAS randomized controlled trials.
- Published in:
- 2007
- By:
- Publication type:
- journal article
Impact of Candesartan on Nonfatal Myocardial Infarction and Cardiovascular Death in Patients With Heart Failure.
- Published in:
- JAMA: Journal of the American Medical Association, 2005, v. 294, n. 14, p. 1794, doi. 10.1001/jama.294.14.1794
- By:
- Publication type:
- Article
Interventions to prevent readmission for congestive heart failure.
- Published in:
- 2004
- By:
- Publication type:
- commentary
Intervention to Prevent Readmission for Congestive Heart Failure.
- Published in:
- 2004
- By:
- Publication type:
- Letter
Even low-dose aspirin inhibits arachidonic acid-induced vasodilation in heart failure<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 2000, v. 67, n. 5, p. 530, doi. 10.1067/mcp.2000.106290
- By:
- Publication type:
- Article
B-type natriuretic peptides in chronic obstructive pulmonary disease: a systematic review.
- Published in:
- 2017
- By:
- Publication type:
- journal article
The Place of Angiotensin-Converting Enzyme Inhibitors in Internal Medicine.
- Published in:
- Medical Principles & Practice, 1989, v. 1, n. 2, p. 65, doi. 10.1159/000157284
- By:
- Publication type:
- Article
Gender- and age-specific rates of heart failure and other adverse cardiovascular outcomes in systemic sclerosis.
- Published in:
- Rheumatology, 2022, v. 61, n. 11, p. 4374, doi. 10.1093/rheumatology/keac072
- By:
- Publication type:
- Article
'Hearts and minds': association, causation and implication of cognitive impairment in heart failure.
- Published in:
- Alzheimer's Research & Therapy, 2015, v. 7, n. 1, p. 1, doi. 10.1186/s13195-015-0106-5
- By:
- Publication type:
- Article
Initiation of Medical Therapy for Heart Failure Patients According to Kidney Function: A Danish Nationwide Study.
- Published in:
- Clinical Epidemiology, 2023, v. 15, p. 855, doi. 10.2147/CLEP.S412787
- By:
- Publication type:
- Article
Lipid-Modifying Therapies and Risk of Pancreatitis: A Meta-analysis.
- Published in:
- JAMA: Journal of the American Medical Association, 2012, v. 308, n. 8, p. 804, doi. 10.1001/jama.2012.8439
- By:
- Publication type:
- Article
Event Rates in Trials of Patients With Type 2 Diabetes.
- Published in:
- 2010
- By:
- Publication type:
- Letter
Initiation of domiciliary care and nursing home admission following first hospitalization for heart failure, stroke, chronic obstructive pulmonary disease or cancer.
- Published in:
- PLoS ONE, 2021, v. 16, n. 8, p. 1, doi. 10.1371/journal.pone.0255364
- By:
- Publication type:
- Article
Statins in the Prevention and Treatment of Heart Failure: a Review of the Evidence.
- Published in:
- Current Atherosclerosis Reports, 2019, v. 21, n. 10, p. N.PAG, doi. 10.1007/s11883-019-0800-z
- By:
- Publication type:
- Article
317-OR: Efficacy and Safety of Dapagliflozin by Glycemic Status in the DAPA-CKD Trial.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-317-OR
- By:
- Publication type:
- Article
130-LB: Dapagliflozin and the Incidence of Type 2 Diabetes in Patients with Chronic Kidney Disease.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-130-LB
- By:
- Publication type:
- Article
1421-P: The Impact of Blood Pressure on Risk of Death Is Influenced by Prior Cardiovascular Disease in Patients with Type 2 Diabetes and a Recent Coronary Event.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-1421-P
- By:
- Publication type:
- Article
1418-P: Increased Risk of Incident Heart Failure and All-Cause Mortality in Insulin-Resistant People with Type 2 Diabetes in the United Kingdom Prospective Diabetes Study (UKPDS).
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-1418-P
- By:
- Publication type:
- Article
2-OR: Impact of N Terminal Pro B-Type Natriuretic Peptide and High Sensitivity Cardiac Troponin on the Prediction of Death and Cardiovascular Events in High-Risk Patients with Type 2 Diabetes.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-2-OR
- By:
- Publication type:
- Article
1112-P: Does Background T2D Therapy Modify the Benefits of Dapagliflozin in Heart Failure? Analysis of the DAPA-HF Trial.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-1112-P
- By:
- Publication type:
- Article
1479-P: Predictors of Incident Hospitalization for Heart Failure in the ACE Trial Population.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-1479-P
- By:
- Publication type:
- Article
Effects of sacubitril/valsartan on glycemia in patients with diabetes and heart failure: the PARAGON-HF and PARADIGM-HF trials.
- Published in:
- Cardiovascular Diabetology, 2022, v. 21, n. 1, p. 1, doi. 10.1186/s12933-022-01545-1
- By:
- Publication type:
- Article
Regional contributions to impaired myocardial mechanical function in heart failure with preserved ejection fraction.
- Published in:
- European Heart Journal - Cardiovascular Imaging, 2023, v. 24, n. 8, p. 1110, doi. 10.1093/ehjci/jead062
- By:
- Publication type:
- Article
Effect of Neladenoson Bialanate on Exercise Capacity Among Patients With Heart Failure With Preserved Ejection Fraction: A Randomized Clinical Trial.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Baseline Characteristics of the Nateglinide and Valsartan Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) Trial Population: Comparison with Other Diabetes Prevention Trials.
- Published in:
- Cardiovascular Therapeutics, 2010, v. 28, n. 2, p. 124, doi. 10.1111/j.1755-5922.2010.00146.x
- By:
- Publication type:
- Article
Correction: Multimorbidity in patients with heart failure from 11 Asian regions: A prospective cohort study using the ASIAN-HF registry.
- Published in:
- 2018
- By:
- Publication type:
- Correction Notice
Correction: Multimorbidity in patients with heart failure from 11 Asian regions: A prospective cohort study using the ASIAN-HF registry.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Multimorbidity in patients with heart failure from 11 Asian regions: A prospective cohort study using the ASIAN-HF registry.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Analysis of on-treatment cancer safety events with daprodustat versus conventional erythropoiesis-stimulating agents—post hoc analyses of the ASCEND-ND and ASCEND-D trials.
- Published in:
- Nephrology Dialysis Transplantation, 2023, v. 38, n. 8, p. 1890, doi. 10.1093/ndt/gfac342
- By:
- Publication type:
- Article
Extrapolated longer-term effects of the DAPA-CKD trial: a modelling analysis.
- Published in:
- Nephrology Dialysis Transplantation, 2023, v. 38, n. 5, p. 1260, doi. 10.1093/ndt/gfac280
- By:
- Publication type:
- Article
ASCEND-ND trial: study design and participant characteristics.
- Published in:
- Nephrology Dialysis Transplantation, 2022, v. 37, n. 11, p. 2157, doi. 10.1093/ndt/gfab318
- By:
- Publication type:
- Article
Safety and efficacy of dapagliflozin in patients with focal segmental glomerulosclerosis: a prespecified analysis of the dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) trial.
- Published in:
- Nephrology Dialysis Transplantation, 2022, v. 37, n. 9, p. 1647, doi. 10.1093/ndt/gfab335
- By:
- Publication type:
- Article
Study design and baseline characteristics of patients on dialysis in the ASCEND-D trial.
- Published in:
- Nephrology Dialysis Transplantation, 2022, v. 37, n. 5, p. 960, doi. 10.1093/ndt/gfab065
- By:
- Publication type:
- Article
The dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) trial: baseline characteristics.
- Published in:
- Nephrology Dialysis Transplantation, 2020, v. 35, n. 10, p. 1700, doi. 10.1093/ndt/gfaa234
- By:
- Publication type:
- Article